Prestige Wealth Management Group’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.79K Buy
27
+3
+13% +$254 ﹤0.01% 785
2026
Q1
$2.39K Buy
24
+2
+9% +$261 ﹤0.01% 706
2025
Q4
$2.68K Hold
22
﹤0.01% 701
2025
Q3
$2.47K Hold
22
﹤0.01% 702
2025
Q2
$2.95K Sell
22
-1
-4% -$110 ﹤0.01% 665
2025
Q1
$1.55K Buy
23
+17
+283% +$1.17K ﹤0.01% 791
2024
Q4
$375 Buy
+6
New +$559 ﹤0.01% 999

Other funds holding TMDX

Prestige Wealth Management Group's TMDX Position: Q2 2026 in Review

Prestige Wealth Management Group increased its Transmedics (TMDX) stake by 13% in Q2 2026, buying an estimated $254 and bringing the position to 27 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #785.

Prestige Wealth Management Group first reported a position in TMDX in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.95K in Q2 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Prestige Wealth Management Group held 27 shares of Transmedics worth $1.79K as of Q2 2026.
  • Prestige Wealth Management Group bought 3 Transmedics shares in Q2 2026, an estimated $254.
  • Transmedics made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #785 holding.
  • Prestige Wealth Management Group first reported a position in Transmedics in Q4 2024 and has held it in 7 quarters since.
  • Prestige Wealth Management Group's Transmedics position peaked at $2.95K in Q2 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.